July 20, 2021 USA
bioprocessonline.com: A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
On this week's episode of The Business of Biotech, Diamyd Medical President & CEO Dr. Ulf Hannelius tells us all about the therapies his company is developing, plus the why and the how behind the company's choice to manufacture them in-house.
Listen to the podcast here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.